对V. 图兰等人的回复 - Suppr

Suppr

超能文献

Reply to V. Turan et al.

作者信息

Blumenfeld Zeev

机构信息

Zeev Blumenfeld, MD, Technion-Israel Institute of Technology, Haifa, Israel.

出版信息

J Clin Oncol. 2019 Jan 1;37(1):88-89. doi: 10.1200/JCO.18.00599. Epub 2018 Nov 8.

DOI:10.1200/JCO.18.00599

PMID:30407896

Abstract

摘要

相似文献

Reply to V. Turan et al.

J Clin Oncol. 2019 Jan 1;37(1):88-89. doi: 10.1200/JCO.18.00599. Epub 2018 Nov 8.

Reply to V. Turan et al.

J Clin Oncol. 2019 Jan 1;37(1):86-88. doi: 10.1200/JCO.18.00630. Epub 2018 Nov 8.

Reply to Z. Blumenfeld et al.

J Clin Oncol. 2013 Oct 10;31(29):3722-3. doi: 10.1200/JCO.2013.50.7129. Epub 2013 Sep 3.

Failure of Ovarian Suppression With Gonadotropin-Releasing Hormone Analogs to Preserve Fertility: An Assessment Based on the Quality of Evidence.

JAMA Oncol. 2016 Jan;2(1):74-5. doi: 10.1001/jamaoncol.2015.3252.

Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.

JAMA Oncol. 2016 Jan;2(1):65-73. doi: 10.1001/jamaoncol.2015.3251.

Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors.

Cancer Res Treat. 2017 Oct;49(4):1153-1163. doi: 10.4143/crt.2016.463. Epub 2017 Feb 27.

Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer.

J Clin Oncol. 2016 May 10;34(14):1580-3. doi: 10.1200/JCO.2015.62.3728. Epub 2016 Jan 4.

Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.

Fertil Steril. 2014 Aug;102(2):488-495.e3. doi: 10.1016/j.fertnstert.2014.05.017. Epub 2014 Jun 14.

Reply to M. Lambertini et al.

J Clin Oncol. 2017 Mar;35(7):805-806. doi: 10.1200/JCO.2016.70.6093. Epub 2016 Nov 28.

Reply to M. Lambertini et al.

J Clin Oncol. 2017 Mar;35(7):807-809. doi: 10.1200/JCO.2016.70.6101. Epub 2016 Nov 28.

引用本文的文献

Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy.

Clin Med Insights Reprod Health. 2019 Aug 21;13:1179558119870163. doi: 10.1177/1179558119870163. eCollection 2019.

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?

Clin Med Insights Reprod Health. 2019 Mar 9;13:1179558119828393. doi: 10.1177/1179558119828393. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Reply to V. Turan et al.

作者信息

Blumenfeld Zeev

机构信息

Zeev Blumenfeld, MD, Technion-Israel Institute of Technology, Haifa, Israel.

出版信息

J Clin Oncol. 2019 Jan 1;37(1):88-89. doi: 10.1200/JCO.18.00599. Epub 2018 Nov 8.

DOI:10.1200/JCO.18.00599

PMID:30407896

Abstract

摘要

相似文献

Reply to V. Turan et al.

J Clin Oncol. 2019 Jan 1;37(1):88-89. doi: 10.1200/JCO.18.00599. Epub 2018 Nov 8.

Reply to V. Turan et al.

J Clin Oncol. 2019 Jan 1;37(1):86-88. doi: 10.1200/JCO.18.00630. Epub 2018 Nov 8.

Reply to Z. Blumenfeld et al.

J Clin Oncol. 2013 Oct 10;31(29):3722-3. doi: 10.1200/JCO.2013.50.7129. Epub 2013 Sep 3.

Failure of Ovarian Suppression With Gonadotropin-Releasing Hormone Analogs to Preserve Fertility: An Assessment Based on the Quality of Evidence.

JAMA Oncol. 2016 Jan;2(1):74-5. doi: 10.1001/jamaoncol.2015.3252.

Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.

JAMA Oncol. 2016 Jan;2(1):65-73. doi: 10.1001/jamaoncol.2015.3251.

Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors.

Cancer Res Treat. 2017 Oct;49(4):1153-1163. doi: 10.4143/crt.2016.463. Epub 2017 Feb 27.

Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer.

J Clin Oncol. 2016 May 10;34(14):1580-3. doi: 10.1200/JCO.2015.62.3728. Epub 2016 Jan 4.

Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.

Fertil Steril. 2014 Aug;102(2):488-495.e3. doi: 10.1016/j.fertnstert.2014.05.017. Epub 2014 Jun 14.

Reply to M. Lambertini et al.

J Clin Oncol. 2017 Mar;35(7):805-806. doi: 10.1200/JCO.2016.70.6093. Epub 2016 Nov 28.

Reply to M. Lambertini et al.

J Clin Oncol. 2017 Mar;35(7):807-809. doi: 10.1200/JCO.2016.70.6101. Epub 2016 Nov 28.

引用本文的文献

Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy.

Clin Med Insights Reprod Health. 2019 Aug 21;13:1179558119870163. doi: 10.1177/1179558119870163. eCollection 2019.

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?

Clin Med Insights Reprod Health. 2019 Mar 9;13:1179558119828393. doi: 10.1177/1179558119828393. eCollection 2019.